Q: Hi 5i Team - Could you please provide an update on the fundamentals of Questor. In particular its cash balance, debt level, insider ownership and recent activity, cash flow, P/E as well as anticipated P/E, and anything else you think is relevant. Also your opinion on its growth prospects and do you think these growth prospects rely completely on the future of the energy sector. Do you think Questor has the ability to outlast a sustained energy downturn. I ask this as an existing shareholder considering selling part of my position (at a substantial loss) and allocating the money somewhere else. Your research and advice has always been very helpful and greatly appreciated! Thanks.
Q: Hello 5i Could you comment on the effect of Route 1 ROI announcing June 1/20 that they won a contract to supply the state of California the state-of-the-art Automatic License Plate Recognition ("ALPR") system that will enhance officer safety.
They seem to have good technology but the stock price languishes.
Q: Can you tell me the difference between net income and adjust net income? What are companies adjusting for? Also, when there is a street estimate, and analysts estimating for net income or an adjusted figure?
Q: I am contemplating to sell GUD and CCL.b from my registered accounts due to their lack of performance. Please advise if the still good to continue hold at the current market conditions ? If not, which one should be sold first ? Thank you. Bill
Q: I don't own Sherritt thankfully. You note today (July 31) in your response to a question on CNC that nickel prices may strengthen due to electric battery demand. Do you think this will help S or are is the company too far gone? S used to own a nickel mine or smelter to Cuba. Does S still have nickel resources in Cuba and if so do you think a Democratic victory this November will ease restrictions on the import of Cuban nickel into the United States? Any comments on S's cobalt warrants? Are the holders in the money?
Thanks,
Jim
Q: Peter, Ryan and staff; RPRX has been suggested as a reasonable entery into the US Pharmaceutical industry. I personally know little of the industry so your opinion would be greatly appreciated.
Your past advice and suggestions have made retirement quite enjoyable. Thank you in advance for your help.
Q: In researching key ratios for a particular company, one metric is cash flow.
Could you please explain the difference between price to cash flow vs. price to free cash flow and what might be a reasonable target in each case.
Thanks, Brian
Q: I’ve held this stock for a few years thanks to your recommendation! Just wondering if buying in right now would be a good idea seeing as the semiconductor space is on a roll. Thank you for your fantastic service.
Q: I purchased BEP.UN on July 30, 2020. On that day, the CFRA report available through my bank's investorline site had it down as a 'hold'. Then, the next day (July 31st ), CFRA had it down as a 'buy' and then on Aug 2nd as a 'sell'. I usually sell when CFRA advises to sell. My questions are:
1) How can CFRA ratings change this quickly?
2) How reliable are CFRAs ratings?
3) Should I sell?
Thanks for your help
Q: good morning, do you have any thoughts on FUSN. Prospects for growth, challenges etc. The company comes with a good pedigree but do you think that will translate into a successful business? thanks